Among the stock activity stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer report...READ MORE
(NEW YORK)Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing ...READ MORE
(WOODCLIFF LAKE, N.J.)Generic drug developer Par Pharmaceutical Cos. slashed its full-year profit outlook late Thursday as competition intensifies and sales decline. The company now expects adjusted ful...READ MORE
(WOODCLIFF LAKE, N.J.)Generic drug developer Par Pharmaceutical Cos. said late Thursday it swung to a second-quarter loss as revenue fell amid more intense competition and lower royalties.READ MORE
(NEW YORK)Standard & Poor's announced on Wednesday online travel company Priceline.com will replace Kemet Corp. in the S&P MidCap 400 after close of trading Friday.READ MORE
(NEW YORK)Par Pharmaceutical Cos. shares rose Monday after the company said the Food and Drug Administration approved its generic version of Solvay Pharmaceutical's chemotherapy side eff...READ MORE
(NEW YORK)Shares of drug developer Biovail Corp. sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts w...READ MORE